Brief: Biovaxys Technology Will Experience Short Term Delay In Filing Its Audited Annual Financial Statements For Year Ended October 31, 2023
21/02/2024 23:18
Feb 21 (Reuters) - Biovaxys Technology Corp BIOV.CD :
* BIOVAXYS TECHNOLOGY - ANTICIPATES WILL EXPERIENCE SHORT
TERM
DELAY IN FILING ITS AUDITED ANNUAL FINANCIAL STATEMENTS FOR YEAR
ENDED OCTOBER 31, 2023
Source text for Eikon: ID:nCNW3vBwVa
Further company coverage: BIOV.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biovaxys Technology
See all newsBrief: Biovaxys Appoints Former Sanofi Vaccines Executive To Board Of Directors
Brief: Biovaxys Announces Life Offering
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000